Related references
Note: Only part of the references are listed.FunRich: An open access standalone functional enrichment and interaction network analysis tool
Mohashin Pathan et al.
PROTEOMICS (2015)
Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro
Tyson J. Smyth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Early diagnostic value of survivin and its alternative splice variants in breast cancer
Salma Khan et al.
BMC CANCER (2014)
A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma
Isabel Poschke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways
Timothy H. Ung et al.
CANCER SCIENCE (2014)
Immunotherapy advances for glioblastoma
David A. Reardon et al.
NEURO-ONCOLOGY (2014)
Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion
Safinur Atay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Antibody-Based Immunotherapy for Malignant Glioma
Patrick C. Gedeon et al.
SEMINARS IN ONCOLOGY (2014)
Regulation of immune responses by extracellular vesicles
Paul D. Robbins et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Exosomes from Murine-derived GL26 Cells Promote Glioblastoma Tumor Growth by Reducing Number and Function of CD8+T Cells
Zhi-Ming Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)
Theresa L. Whiteside
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Molecular Pathways: Tumor-Derived Microvesicles and Their Interactions with Immune Cells In Vivo
Ferdinando Pucci et al.
CLINICAL CANCER RESEARCH (2013)
Treatment Options in Newly Diagnosed Glioblastoma
Eudocia Q. Lee et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2013)
Long-term survival of patients with glioblastoma multiforme (GBM)
Nicolas R. Smoll et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Heparin blocks transfer of extracellular vesicles between donor and recipient cells
Nadia A. Atai et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
C-src Enriched Serum Microvesicles Are Generated in Malignant Plasma Cell Dyscrasia
Giuseppe Di Noto et al.
PLOS ONE (2013)
Induction of the Unfolded Protein Response Drives Enhanced Metabolism and Chemoresistance in Glioma Cells
Laura M. Epple et al.
PLOS ONE (2013)
Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development
Paulina Kucharzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Host Matrix Modulation by Tumor Exosomes Promotes Motility and Invasiveness
Wei Mu et al.
NEOPLASIA (2013)
Biochemical and Biologic Characterization of Exosomes and Microvesicles as Facilitators of HIV-1 Infection in Macrophages
Irena Kadiu et al.
JOURNAL OF IMMUNOLOGY (2012)
Exosome removal as a therapeutic adjuvant in cancer
Annette M. Marleau et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Medulloblastoma Exosome Proteomics Yield Functional Roles for Extracellular Vesicles
Laura M. Epple et al.
PLOS ONE (2012)
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC
Christina Battke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments
Douglas D. Taylor et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Exosomal-like vesicles with immune-modulatory features are present in human plasma and can induce CD4+T-cell apoptosis in vitro
Yana Ren et al.
TRANSFUSION (2011)
Glioblastoma-Derived Mechanisms of Systemic Immunosuppression
Allen Waziri
NEUROSURGERY CLINICS OF NORTH AMERICA (2010)
Dynamics of central and peripheral immunomodulation in a murine glioma model
Benjamin C. Kennedy et al.
BMC IMMUNOLOGY (2009)
Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
Guilherme Rabinowits et al.
CLINICAL LUNG CANCER (2009)
FDA Drug Approval Summary: Bevacizumab (Avastin (R)) as Treatment of Recurrent Glioblastoma Multiforme
Martin H. Cohen et al.
ONCOLOGIST (2009)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Novel anti-angiogenic therapies for malignant gliomas
Andrew D. Norden et al.
LANCET NEUROLOGY (2008)
Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro
G. Li et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
PE Fecci et al.
CANCER RESEARCH (2006)
Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function
CR Liu et al.
JOURNAL OF IMMUNOLOGY (2006)
Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles
Eva Wieckowski et al.
IMMUNOLOGIC RESEARCH (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Malignant effusions and immunogenic tumour-derived exosomes
F Andre et al.
LANCET (2002)
Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer
CHJ Lamers et al.
CANCER GENE THERAPY (2002)
Share Paper
